BBVA USA’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.16M Sell
20,015
-951
-5% -$58.6K 0.07% 244
2021
Q2
$1.33M Buy
+20,966
New +$1.38M 0.07% 239

Other funds holding XRAY

BBVA USA's XRAY Position: Q3 2021 in Review

BBVA USA reduced its Dentsply Sirona (XRAY) stake by 4.5% in Q3 2021, selling an estimated $58.6K and leaving 20,015 shares worth $1.16M. The position accounts for 0.07% of the portfolio, ranked #244.

BBVA USA first reported a position in XRAY in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.33M in Q2 2021. 553 funds tracked by Wall St. Rank hold XRAY as of Q3 2021.

  • BBVA USA held 20,015 shares of Dentsply Sirona worth $1.16M as of Q3 2021.
  • BBVA USA sold 951 Dentsply Sirona shares in Q3 2021, an estimated $58.6K.
  • Dentsply Sirona made up 0.07% of BBVA USA's portfolio in Q3 2021, its #244 holding.
  • BBVA USA first reported a position in Dentsply Sirona in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Dentsply Sirona position peaked at $1.33M in Q2 2021.
  • 553 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.